Damle N K, Klussman K, Leytze G, Linsley P S
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA 98121.
J Immunol. 1993 Feb 1;150(3):726-35.
Staphylococcal enterotoxins, also known as superantigens (SAg), bind class II MHC molecules on APC and upon direct cell-to-cell contact stimulate proliferation of T cells expressing appropriate V beta gene products. The T cell surface molecule CD28 binds its costimulatory counter-receptor, B7 expressed on APC, and augments IL-2 production and T cell growth. Although the role of B7 costimulation during Ag-specific responses of T cells is established, its involvement during the activation of T cells with SAg has not been examined. Using a soluble Ig C gamma 1 chimera of CTLA-4, a second receptor for B7 and a homologue of CD28, this study examines the role of B7 expressed on APC during the induction of proliferation of CD4+ T cells upon stimulation with SAg (SAg/staphylococcal enterotoxins). CTLA-4lg, which has a higher avidity for B7 than CD28, had no effect on the synthesis of IL-2 as well as proliferative responses of CD4+ T cells induced by SAg presented on allogeneic EBV-transformed B cells, and IFN-gamma-activated endothelial cells. In contrast, T cell proliferation induced by alloAg presentation by the same APC was significantly inhibited by CTLA-4lg. mAb directed at the CD11a/CD18 molecule inhibited both SAg-induced and alloAg-induced proliferation of T cells. AlloAg-primed CD4+ T cells, which expressed both class II MHC and intercellular adhesion molecule-1 but not B7, presented SAg to and induced proliferation of both resting and SAg-primed T cells. These responses were inhibited by mAb directed at CD11a/CD18 but not by CTLA-4 Rg. These results suggest that SAg-induced responses differ from those induced by alloAg in that they are not obligatorily dependent on the costimulation by B7. In contrast, adhesive interaction between CD11a/CD18 on T cells and its counter-receptor on SAg-presenting cells is necessary and probably sufficient to support SAg-induced proliferation of T cells.
葡萄球菌肠毒素,也被称为超抗原(SAg),可与抗原呈递细胞(APC)上的II类主要组织相容性复合体(MHC)分子结合,并在细胞间直接接触时刺激表达合适Vβ基因产物的T细胞增殖。T细胞表面分子CD28与其共刺激配对受体、APC上表达的B7结合,增强白细胞介素-2(IL-2)的产生和T细胞生长。尽管B7共刺激在T细胞的抗原特异性反应中的作用已得到确立,但其在超抗原激活T细胞过程中的参与情况尚未得到研究。本研究使用细胞毒性T淋巴细胞相关抗原4(CTLA-4)的可溶性免疫球蛋白Cγ1嵌合体(B7的第二种受体和CD28的同源物),来研究APC上表达的B7在超抗原刺激CD4 + T细胞增殖诱导过程中的作用(超抗原/葡萄球菌肠毒素)。对B7的亲和力高于CD28的CTLA-4Ig,对由同种异体EB病毒转化的B细胞以及干扰素-γ激活的内皮细胞呈递的超抗原诱导的CD4 + T细胞的IL-2合成及增殖反应均无影响。相比之下,相同APC呈递同种异体抗原诱导的T细胞增殖则被CTLA-4Ig显著抑制。针对CD11a/CD18分子的单克隆抗体抑制了超抗原诱导和同种异体抗原诱导的T细胞增殖。预先用同种异体抗原致敏的CD4 + T细胞,既表达II类MHC又表达细胞间黏附分子-1但不表达B7,可将超抗原呈递给静止的和预先用超抗原致敏的T细胞并诱导其增殖。这些反应被针对CD11a/CD18的单克隆抗体抑制,但未被CTLA-4Ig抑制。这些结果表明,超抗原诱导的反应不同于同种异体抗原诱导的反应,因为它们不一定依赖于B7的共刺激。相比之下,T细胞上的CD11a/CD18与其在超抗原呈递细胞上的配对受体之间的黏附相互作用是必要的,并且可能足以支持超抗原诱导的T细胞增殖。